ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2322

Quantitative Proteomics Comparison of Children with Inactive and Active Uveitis

Sheila Angeles-Han1, Duc Duong2, Steven Yeh3, Purnima Patel4, Virginia Miraldi Utz5, Kirsten Jenkins6, Danielle Lowe7, Sampath Prahalad8 and Gary Holland9, 1Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH, 2Emory University, Atlanta, GA, 3Ophthalmology, Emory University School of Medicine, Atlanta, GA, 4Emory University School of Medicine, Atlanta, GA, 5Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH, 6Children's Healthcare of Atlanta, Atlanta, GA, 7Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, 9Jules Stein Eye Institute, Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Biomarkers, juvenile idiopathic arthritis (JIA), proteomics and uveitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Pediatric Rheumatology – Pathogenesis and Genetics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Children with chronic non-infectious uveitis are at high risk for sight-threatening complications and vision loss. No biomarker predicts uveitis development or treatment response. Aqueous humor has been studied but is not feasible to collect in children with JIA without eye disease.  Tear proteomics is increasingly used for biomarker discovery in ocular and non-ocular diseases.  Advantages of tear collection are easy accessibility, non-invasiveness and tolerance.  We examined the tear profile of children with uveitis to identify potential markers for activity vs dormancy.

Methods: Tear samples were collected from children with chronic non-infectious uveitis (Table 1). A Schirmer strip was placed 6mm from the lateral canthus of the anesthetized eye for 2-5 minutes.  Then, 50 ug of proteins were extracted for Tandem Mass Tag (TMT) labeling.  The TMT pool was loaded onto an offline electrostatic repulsion interaction chromatography (ERLIC) fractionation HPLC system and 20 fractions were collected. LC-MS/MS analysis was done on all 20 fractions. Proteome Discoverer 2.1 (ThermoFisher Scientific, San Jose, CA) was used to search all the MS/MS spectra against a Uniprot human reference protein database (retrieved April 20, 2015; 90,411 target sequences) and TMT reporter quantitation was performed.

We compared children with 1) active vs inactive uveitis of all locations and 2) active vs. inactive anterior uveitis only (JIA-associated and idiopathic). Active uveitis was defined as anterior chamber cell grade of 0.5+ (1-5 cells/hpf) and greater. Inactive uveitis was grade 0.

Results: There were 19 children (29 eyes) examined.  We quantified 1426 unique protein groups and found 34 and 39 statistically significant proteins, respectively for all uveitis and anterior uveitis only comparisons.  Gene ontology showed pathways related to extracellular exosomes (adjusted p=10.6e-13 for all uveitis locations and p=1.23 e-14 for anterior uveitis only).  In children with anterior uveitis only, there were pathways related to intracellular RNP complex (p=7.47 e-04), poly (A) RNA binding (p=0.002), and cadherin binding involved in cell-cell adhesion (p =0.012).  These results suggest the homeostatic balance of translational and signaling machinery is disrupted during disease activity. 

Conclusion: We identified potential biomarkers that may differentiate active ocular inflammation in children with uveitis.  This may improve our understanding of the underlying mechanisms associated with ocular inflammation in children with JIA.  Discovery of biomarkers in combination with clinical outcome measures may lead to better prediction of uveitis development and response to therapy.

Table 1. Demographics and Clinical Characteristics of Children with Chronic Non-infectious Uveitis, N (%)

 

ALL

N = 19 children

29 eyes

Active

N = 12 children

10 eyes

Inactive

N = 7 children

19 eyes

Female

16 (84)

10 (83)

6 (86)

Race

 

 

 

     Caucasian

13 (68)

6 (50)

7 (100)

     African American

6 (32)

6 (50)

0

Non-Hispanic

17 (89)

10 (83)

7 (100)

Age at uveitis diagnosis

7.6 years

8.5 years

5.8 years

Diagnosis

 

 

 

     JIA-associated uveitis (oligo or poly RF  negative)

9 (5)

5 (42)

4 (57)

     Idiopathic chronic anterior uveitis

5 (26)

4 (33)

1 (14)

     Idiopathic uveitis, not anterior in location

3 (16)

3 (25)

0

     HLA-B27 associated

2 (10)

0

2 (28)

Uveitis location

 

 

 

     Anterior

15 (79)

9 (75)

6 (86)

     Anterior/

     Intermediate

1 (5)

0

1 (14)

     Intermediate

2 (10)

2 (17)

0

     Posterior

1 (5)

1 (8)

0

Bilateral

16 (84)

10 (83)

6 (85)

Medication use at time of collection

 

 

 

     Topical steroids (prednisolone acetate or difluprednate)

12 (63)

10 (83)

2 (28)

     Timolol

3 (16)

3 (25)

0

     Methotrexate

12 (63)

10 (83)

2 (28)

     Mycophenolate

1 (5)

 

1 (14)

     Lefunomide

2 (10)

1 (8)

1 (14)

     Infliximab

6 (32)

3 (25)

3 (43)

     Adalimumab

3 (16)

2 (17)

1 (14)

     Tocilizumab

2 (10)

1 (8)

1 (14)

 


Disclosure: S. Angeles-Han, None; D. Duong, None; S. Yeh, None; P. Patel, None; V. Miraldi Utz, None; K. Jenkins, None; D. Lowe, None; S. Prahalad, None; G. Holland, None.

To cite this abstract in AMA style:

Angeles-Han S, Duong D, Yeh S, Patel P, Miraldi Utz V, Jenkins K, Lowe D, Prahalad S, Holland G. Quantitative Proteomics Comparison of Children with Inactive and Active Uveitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/quantitative-proteomics-comparison-of-children-with-inactive-and-active-uveitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-proteomics-comparison-of-children-with-inactive-and-active-uveitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology